NEW YORK, March 2 (GenomeWeb News) - Tranzyme Pharma today said that it has expanded a strategic alliance it began in 2002 with BD Technologies, a unit of Becton, Dickinson and Company.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.